ABO-incompatible liver transplantation using only rituximab for patients with low anti-ABO antibody titer

BACKGROUNDS/AIMS: Graft survival after ABO-incompatible (ABOi) living donor liver transplantation (LDLT) has increased due to advances in desensitization methods. We analyzed early outcomes following ABOi LDLT using only rituximab without any additional desensitization methods in recipients with low...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Hepatobiliary Pancreat Surg
Main Authors: Lee, Boram, Choi, YoungRok, Han, Ho-Seong, Yoon, Yoo-Seok, Cho, Jai Young, Jeong, Sook-Hyang, Kim, Jin-Wook, Jang, Eun Sun, Ahn, Soomin
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Association of Hepato-Biliary-Pancreatic Surgery 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6728259/
https://ncbi.nlm.nih.gov/pubmed/31501808
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14701/ahbps.2019.23.3.211
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados